Free public records show CorrectSequence Therapeutics Co., Ltd in 2 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by CorrectSequence Therapeutics Co., Ltd or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
7 active studies led by CorrectSequence Therapeutics Co., Ltd, of 9 in all
Source: ClinicalTrials.gov, Studies with CorrectSequence Therapeutics Co., Ltd (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies CorrectSequence Therapeutics Co., Ltd leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with CorrectSequence Therapeutics Co., Ltd or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show CorrectSequence Therapeutics Co., Ltd: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets CorrectSequence Therapeutics Co., Ltd is in.
Stories on the topics CorrectSequence Therapeutics Co., Ltd works in.
Omega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart.
Read
WHO says only about half of patients in developed countries take long-term medicines as prescribed. Patient…
Read
Cardiovascular disease is the world's leading cause of death, and stroke caused 11.9 million new cases in…
ReadSearch all reports for CorrectSequence Therapeutics Co., Ltd All companies